Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
about
Anticancer mechanisms of cannabinoidsSurvival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomasA new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.A murine model of targeted infusion for intracranial tumors.Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidN-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87.Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral actionLow-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.Dendritic cell-based active specific immunotherapy for malignant glioma.Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomasTreatment options for recurrent glioblastoma: pitfalls and future trends.Intra-arterial chemotherapy for malignant gliomas: a critical analysis.Contribution of case reports to glioblastoma research: systematic review and analysis of pattern of citation.Pseudoprogression after glioma therapy: a comprehensive review.A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG).The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.Perspectives of Medical Specialists on Sharing Decisions in Cancer Care: A Qualitative Study Concerning Chemotherapy Decisions With Patients With Recurrent Glioblastoma.The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas.The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.The transglutaminase 2 gene is aberrantly hypermethylated in gliomaAn investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.Unmet needs in the treatment of glioblastoma.Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?MicroRNA miR-1249 downregulates adenomatous polyposis coli 2 expression and promotes glioma cells proliferation.Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma.Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study.Calcium overload induces C6 rat glioma cell apoptosis in sonodynamic therapy.
P2860
Q26750399-3C983877-4088-4794-A6E9-C5BB0F04C63CQ31033595-37F7D81E-BF4A-4155-BCFD-7768CF503D6BQ33391296-96A4A2C0-211B-43ED-AA1E-1B8777BFA5B9Q33570393-904078BC-0034-446A-906B-908A5267D8A1Q33848111-7DB7ABDE-6BDC-4D76-B61B-2E1EA7254B39Q34732908-4F3FBEBE-E677-4EDA-A4D8-F67C4BFA9E97Q34786475-1ECB9612-C905-4FEB-850C-0D5C312B497BQ35056313-630F6DD5-C518-498E-9082-77492BCB9099Q35092693-839DF5DE-829F-4D04-B22A-968E0FCD2CFBQ35633819-DBF91B25-10FC-4754-85F4-44B58383FEEAQ35755392-06D16E22-C2F7-4D47-A958-2F7B0E4EF00FQ36764903-A8B24BED-73FE-42C8-92D0-CDA02FE1475BQ37248489-ADC2D72B-E53E-48C3-8217-E15FA2835AB4Q37331142-A035406F-71A1-4959-9942-E39CD4CDFCBCQ37483971-7430C74C-AE3B-4E5E-8507-6076243937B0Q37946674-E61AA581-67F1-4D84-943B-FB14FDCB452DQ38017692-76B9445E-959C-4F89-A1CD-5965613F05B5Q38094809-EF9ED0C2-F69B-48B7-BC30-9CCFBC7A2243Q38161380-86C9B4D9-8B2F-49A9-A36F-A8083813BE74Q38205134-36E6F058-7882-419C-9F26-9D7CD7590F36Q39256859-1E4D7CE2-997E-4FF9-8E90-7BE92CE33793Q39613855-0DD52F45-B007-46A5-A54F-C452622ADD67Q41450286-4E052457-3216-4E7F-BD3E-A6195674BBAFQ41505438-25120BF1-FFC0-484D-AF31-4B479282539DQ41539725-81FD437B-4B47-4763-B403-3B8FD7E19F58Q41903416-1F0DA274-04B7-4BC2-BFF0-CBD763FCF1FFQ46735548-88EBB50D-3916-4F55-9397-C6A875916C94Q48614301-55AA1A01-E875-42E0-BAEC-AC34CADCB93BQ48658616-B824D168-343A-4358-9C8A-1309C48A053EQ54975281-86CF2EFF-86E3-4BD7-8DF8-6E69B169AF67Q55458536-DC17A244-EDA3-4B0C-9FA1-B03AEB50CADCQ55461251-79D91446-153D-419D-B2C8-BBC756081580Q55461270-384B052D-BE5C-444E-AAAD-C777DF4859E9Q55462834-6AAEC514-A448-485B-97A7-1D59A22001AC
P2860
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@ast
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@en
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@nl
type
label
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@ast
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@en
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@nl
prefLabel
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@ast
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@en
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@nl
P2093
P1476
Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
@en
P2093
Anca L Grosu
Carsten Nieder
Markus Adam
Michael Molls
P304
P356
10.1016/J.CRITREVONC.2006.06.007
P577
2006-07-27T00:00:00Z